Medications & Supplements/Prescription Drugs

Nostrum Laboratories Inc: Calcium Acetate Capsules Recalled for Presence of Foreign Tablets/Capsules

Agency Publication Date: February 20, 2018

Summary

Nostrum Laboratories Inc. is recalling 1,439,000 bottles of Calcium Acetate (667 mg) capsules because a bottle was found to contain foreign tablets or capsules. This prescription medication is used to control phosphate levels in patients with kidney disease. Consumers should be aware that the presence of an incorrect medication in the bottle means you may not be receiving your intended treatment or could be exposed to an unknown drug. This recall affects 200-count bottles distributed nationwide.

Risk

The presence of foreign tablets or capsules poses a risk because a patient might accidentally ingest the wrong medication, leading to a lack of therapeutic effect for their condition or unintended side effects and adverse reactions from the foreign substance.

What You Should Do

Immediately check your medication bottle to see if it is affected. Look for 'Calcium Acetate Capsules, 667 mg' in a 200-count bottle with NDC 29033-026-02.
Verify the specific lot number and expiration date on the label. This recall only affects Lot CAL173502 with an expiration date of 09/19.
If you identify an affected bottle, stop using the medication and contact your healthcare provider or pharmacist immediately for guidance on a replacement and to ensure your treatment is not interrupted.
Return any unused portions of the recalled medication to the pharmacy where you purchased it for a refund.
Contact the manufacturer, Nostrum Laboratories Inc., at their Kansas City facility if you have questions regarding the return process.
For further questions or to report adverse events, contact the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) or visit www.fda.gov/safety/recalls.

Your Remedy Options

Full Refund

Healthcare provider consultation and pharmacy refund

How to: Contact your healthcare provider or pharmacist for guidance. Return any unused product to the pharmacy for a refund

Affected Products

Product: Calcium Acetate Capsules (667 mg, 200 Capsules per bottle)

Model:

NDC 29033-026-02

Recall #: D-0473-2018

Lot Numbers:

CAL173502 (Exp. 09/19)

Date Ranges: Exp. 09/19

Additional Information

Agency: Food and Drug Administration (FDA)

Event ID: 79210

Status: Resolved

Manufacturer: Nostrum Laboratories Inc

Sold By: pharmacies; healthcare providers

Manufactured In: United States

Units Affected: 1,439,000 oral capsules

Distributed To: Nationwide

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES · Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.

Summary

What You Should Do

Immediately check your medication bottle to see if it is affected. Look for 'Calcium Acetate Capsules, 667 mg' in a 200-count bottle with NDC 29033-026-02.

Verify the specific lot number and expiration date on the label. This recall only affects Lot CAL173502 with an expiration date of 09/19.

If you identify an affected bottle, stop using the medication and contact your healthcare provider or pharmacist immediately for guidance on a replacement and to ensure your treatment is not interrupted.

Return any unused portions of the recalled medication to the pharmacy where you purchased it for a refund.

Contact the manufacturer, Nostrum Laboratories Inc., at their Kansas City facility if you have questions regarding the return process.

For further questions or to report adverse events, contact the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) or visit www.fda.gov/safety/recalls.